NSN - 6505-01-427-1064, 6505014271064 of Cetirizine Tablets

Aviation Axis stocks 255551, NDC00378-3637-01, NDC00904-5852-60 - Cetirizine Tablets made by Harvard Drug Group Llc The, Mylan Pharmaceuticals Inc with 6505-01-427-1064. Owned and operated by ASAP Semiconductor, we have access to over 2 billion new and after-market parts applicable within the aerospace and defense industries. All our parts are shipped using our premier shipping and supply chain. We offer short lead-times and some of the fastest shipping times in the industry. We are well-equipped to handle any customer situation - including AOG. Submit an RFQ today and expect a response within 15 minutes or less. ASAP - the evolution of purchasing.

Alternative NSN: 6505-01-427-1064
Item Name: Cetirizine Tablets
NIIN: 014271064
NCB Code: USA (01)
Manufacturers: Harvard Drug Group Llc The, Mylan Pharmaceuticals Inc
Part No Manufacturer Item Name QTY RFQ
255551 harvard drug group llc the cetirizine tablets Avl RFQ
NDC00378-3637-01 mylan pharmaceuticals inc cetirizine tablets Avl RFQ
NDC00904-5852-60 harvard drug group llc the cetirizine tablets Avl RFQ

Technical Characteristics of NSN 6505014271064

MRCCriteriaCharacteristic
CXCYPart Name Assigned By Controlling AgencyCETRIZINE TABLETS 10MG 100S
MRCDecoded RequirementClear Text Reply
TEXTGeneral Characteristics Item Description10 MG; 100'S

Related NSN List for 6505-01-427-1064, 6505014271064

Send Instant RFQ

Low Price

Warrantied inventory at competitive prices

Find it fast

Search the world's largest inventory of electronic components by manufacturer, category or part number

Get it fast

All inventory ready to ship from our sellers

Quality guaranteed

We sell only warrantied and traceable parts

  Semiconductor's Certifications and Memberships

Thanks for Visiting Us today!

Remember, You Can Get A Competitive Quote for Your Parts Within Fifteen Minutes Or Less, Simply by Filling Out the Instant RFQ form On the Homepage.

Request for Quote

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.